TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Dividend Stocks
Could Canopy Growth Corp. Become a Top Dividend Stock?
Stocks for Beginners
How to Use Comparable Company Analysis to Derive the Value of Any Stock
Investing
Canopy Growth Corp.: What Went up in Smoke in 2016?
Investing
Canopy Growth Corp.: Weeding Out the Short-Term Thinkers
Investing
Canopy Growth Corp.: Is it Safe to Buy for 2017?
Energy Stocks
These 3 Stocks Doubled Investors’ Money in 2016
Investing
Canopy Growth Corp.: You Ain’t Seen Nothing Yet
Investing
Canopy Growth Corp.: Why Investors Should Avoid This Stock Today
Investing
Canopy Growth Corp.: What to Do Now That the Hype Has Settled Down
Investing
Why Canopy Growth Corp. Might Crash in 2017
Investing
3 Marijuana Companies Canopy Growth Corp. Investors Should Worry About